Monday, April 17, 2023

Epic Sciences Finds $24M

San Diego-based Epic Sciences has raise $24M in a Series G funding, the company said last week. According to the company, the funding was co-led by Deerfield Management and Arsenal Capital Partners, and also included Blue Ox Healthcare Partners, Domain Ventures, and Labcorp. The company says funds will go towards the commercial launch for its blood-based biopsy result for patients with metastatic breast cancer.